Souderton, Pennsylvania — According to state and local economic development sources Almac Group plans to invest $93,500,000.00 to build out 100,000 square feet of new space in Souderton. The company plans to occupy the new space at 25 Fretz Road in Souderton, on or about February 1, 2024. According to the company website Almac is a financially secure, privately owned organisation with over 6,000 employees located within the US, Europe and Asia. 600+ companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 50 years. Pre-clinical biomarker discovery, through to full companion diagnostic development and clinical test delivery from our CLIA lab. Services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides. Developing clinical candidates into an optimum formulation and manufacturing drug product for all phases of clinical trial supply. Delivering comprehensive solutions supporting drug substance and product development programmes. Comprehensive global clinical supply chain solutions providing physical resources and supportive technologies ensuring your clinical supply chain continually delivers across the globe. Providing randomisation and trial supply management technology, electronic Clinical Outcome Assessments (eCOA), patient alerts and reminders, data integration and biostatistical consulting services. Providing commercial manufacturing and packaging solutions and supporting commercial product launch.

To learn more about Almac Group, visit http://www.almacgroup.com/

Company Contact:
Alan Armstrong, Chief Executive Officer
215-660-8500

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved